Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-12-05
2000-10-10
Allen, Marianne P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241301, 4241841, 4241871, 4241931, 42419611, 4242041, 4242781, 530403, 530806, 530826, A61K 3929, A61K 39205, A61K 4700, C07K 1400
Patent
active
061299219
ABSTRACT:
Methods of enhancing an antigen-induced immune response through use of a ribonucleocapsid complex are provided. Composition containing a ribonucleocapsid complex and an antigen which are capable of enhancing the immune response to the antigen are also provided.
REFERENCES:
patent: 4320115 (1982-03-01), Bijlenga et al.
Fu, Z.F., et al., "Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine", Proc. Natl. Acad. Sci. USA (1991) 88:2001-2005.
Schneider et al., "Rabies Group-Specific Ribonucleo-protein Antigen and a Test System for Grouping and Typing of Rhabdoviruses", J. Virol. (1973) 11:748-755.
Wiktor, T.J., et al., "Induction and Biological Properties of Defective Interfering Particles of Rabies Virus", J. Virol. (1977) 21 626-635.
Erickson, B.W. and Merrifield, R.B. (1976) In: Neurath, H., Hill, R.L. (eds) The Proteins, Academic, New York, vol. 2, p. 255.
Wraith et al. (B). J. Gen. Virol 68: 433-440, 1987.
Dietzschold et al. Immunology 10(5):427-439, 1991.
Herzog et al. Virus Research 24: 77-89, 1992.
Perrin et al. Vaccine (United Kingdom) 9(8): 549-558, 1991.
Fu, Z.F. et al. PNAS (USA) 88: 200-2005, 1991.
Cubitt et al. J. Virol. 68 (3): 1371-1381, 1994.
Oberg et al. J. Virol 65(8): 4486-4489, 1991.
Castaneda et al., J. Virol. 64(1): 222-230,1990.
Wraith et al. (A) J. Gen. Virol. 66:1327-1331, 1985.
Piera et al. Int. J. Cancer 55: 148-152, 1993.
Fu, et al. 1991. Rabies virus nucleoprotein expressed in and purified . . . PNAS, USA. 88:2001-2005.
Dietzschold et al. 1987. Induction of protective immunity against . . . PNAS USA. 84:9165-9169.
Dietzschold Bernhard
Hooper Douglas Craig
Koprowski Hilary
Allen Marianne P.
Thomas Jefferson University
Zeman Mary K
LandOfFree
Viral ribonucleocapsid as an immunological enhancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral ribonucleocapsid as an immunological enhancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral ribonucleocapsid as an immunological enhancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2254319